Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

OTTMUSG00000018981 Inhibitors

The inhibition of ovary testis transcribed isoform X1 is achieved through a variety of mechanisms, each targeting specific cellular pathways and processes that are crucial for the protein's functional activity. Staurosporine, as a kinase inhibitor, prevents the phosphorylation of ovary testis transcribed isoform X1, a process likely essential for its activation or modification. Similarly, LY294002 and Wortmannin, both PI3K inhibitors, disrupt signaling pathways that ovary testis transcribed isoform X1 may rely on for its activity. The inhibition of the PI3K pathway can lead to a cascade of effects, culminating in the functional inhibition of ovary testis transcribed isoform X1. Rapamycin, targeting the mTOR pathway, affects protein synthesis and cellular growth processes, which are potentially vital for the functional expression or post-translational modifications of ovary testis transcribed isoform X1. PD98059 and U0126, both targeting the MAPK/ERK pathway, and SB203580 and SP600125, targeting the p38 MAPK and JNK pathways respectively, impede signaling routes that may regulate or influence the activity of ovary testis transcribed isoform X1. The MAPK pathways, known for their roles in stress responses and cellular regulation, are integral to the functional regulation of many proteins.

Tyrosine kinase inhibitors like Dasatinib, Erlotinib, Imatinib, and Lapatinib, each target different kinases within the cellular signaling networks. These kinases, including BCR-ABL, c-Kit, PDGFR, EGFR, and HER2/neu, are pivotal in various signaling pathways that can regulate or affect the activity of ovary testis transcribed isoform X1. The inhibition of these kinases leads to a reduction in the functional activity of ovary testis transcribed isoform X1 by disrupting the signaling cascades that are crucial for its functional state. Thus, the collective action of these inhibitors, through their specific targets, contributes to the functional inhibition of ovary testis transcribed isoform X1, demonstrating the intricate interplay between cellular signaling pathways and protein functionality.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Imatinib is a tyrosine kinase inhibitor, primarily targeting BCR-ABL, c-Kit, and PDGFR. These kinases are involved in signaling pathways that can influence the function of ovary testis transcribed isoform X1. By inhibiting these kinases, imatinib can reduce the functional activity of ovary testis transcribed isoform X1.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Lapatinib is a dual inhibitor of EGFR and HER2/neu tyrosine kinases. Inhibition of these kinases can affect signaling pathways relevant to the function of ovary testis transcribed isoform X1, leading to its functional inhibition.